BACKGROUND: Since 2006 Human papillomavirus (HPV) vaccination has become
available to adolescent girls and women in an increasing number of countries, to protect …

The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly
100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by …

Recent data demonstrate that human papillomavirus also plays a role in cancers other than
ano-genital cancers, specifically head and neck cancers, and non-cancerous conditions …

Protein instability and immunogenicity are two main roadblocks to the clinical success of
novel protein drug delivery systems. In this commentary, we discuss the need for more …

Objectives To investigate the reasons for refusal of human papillomavirus (HPV)
vaccination, and to explore participants' perceptions and attitudes about Health Belief Model …

Background In clinical trials, vaccines against human papillomavirus (HPV) have been
highly effective against HPV16-or HPV18-associated cervical lesions. The quadrivalent HPV …

Objective Human papillomavirus (HPV) vaccine uptake in many countries has been sub-
optimal. We examine several issues associated with non-vaccination that have received …

Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many
countries for the prevention of cervical cancer, the second most important cause of cancer …

Cancer is a leading cause of death globally, and it is predicted and projected to continue
rising as life expectancy increases. Although patient survival rates for some forms of cancers …

Abstract Problem/Condition: Approximately 12 million people are living with cancer in the
United States. Limited information is available on national and state assessments of health …